BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 27580029)

  • 1. Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition.
    Sciacovelli M; Gonçalves E; Johnson TI; Zecchini VR; da Costa AS; Gaude E; Drubbel AV; Theobald SJ; Abbo SR; Tran MG; Rajeeve V; Cardaci S; Foster S; Yun H; Cutillas P; Warren A; Gnanapragasam V; Gottlieb E; Franze K; Huntly B; Maher ER; Maxwell PH; Saez-Rodriguez J; Frezza C
    Nature; 2016 Aug; 537(7621):544-547. PubMed ID: 27580029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fumarates and Cancer.
    Fuhler GM; Eppinga H; Peppelenbosch MP
    Trends Mol Med; 2017 Jan; 23(1):3-5. PubMed ID: 27986420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncometabolite Accumulation and Epithelial-to-Mesenchymal Transition: The Turn of Fumarate.
    Janin M; Esteller M
    Cell Metab; 2016 Oct; 24(4):529-530. PubMed ID: 27732835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fumarate Hydratase Loss Causes Combined Respiratory Chain Defects.
    Tyrakis PA; Yurkovich ME; Sciacovelli M; Papachristou EK; Bridges HR; Gaude E; Schreiner A; D'Santos C; Hirst J; Hernandez-Fernaud J; Springett R; Griffiths JR; Frezza C
    Cell Rep; 2017 Oct; 21(4):1036-1047. PubMed ID: 29069586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous adaptation of cysteine reactivity to a covalent oncometabolite.
    Perez M; Bak DW; Bergholtz SE; Crooks DR; Arimilli BS; Yang Y; Weerapana E; Linehan WM; Meier JL
    J Biol Chem; 2020 Sep; 295(39):13410-13418. PubMed ID: 32820045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fumarate drives EMT in renal cancer.
    Sciacovelli M; Frezza C
    Cell Death Differ; 2017 Jan; 24(1):1-2. PubMed ID: 27886164
    [No Abstract]   [Full Text] [Related]  

  • 7. mTORC1 Upregulation Leads to Accumulation of the Oncometabolite Fumarate in a Mouse Model of Renal Cell Carcinoma.
    Drusian L; Nigro EA; Mannella V; Pagliarini R; Pema M; Costa ASH; Benigni F; Larcher A; Chiaravalli M; Gaude E; Montorsi F; Capitanio U; Musco G; Frezza C; Boletta A
    Cell Rep; 2018 Jul; 24(5):1093-1104.e6. PubMed ID: 30067967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase.
    Frezza C; Zheng L; Folger O; Rajagopalan KN; MacKenzie ED; Jerby L; Micaroni M; Chaneton B; Adam J; Hedley A; Kalna G; Tomlinson IP; Pollard PJ; Watson DG; Deberardinis RJ; Shlomi T; Ruppin E; Gottlieb E
    Nature; 2011 Aug; 477(7363):225-8. PubMed ID: 21849978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors.
    Xiao M; Yang H; Xu W; Ma S; Lin H; Zhu H; Liu L; Liu Y; Yang C; Xu Y; Zhao S; Ye D; Xiong Y; Guan KL
    Genes Dev; 2012 Jun; 26(12):1326-38. PubMed ID: 22677546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of mitochondrial aconitase by succination in fumarate hydratase deficiency.
    Ternette N; Yang M; Laroyia M; Kitagawa M; O'Flaherty L; Wolhulter K; Igarashi K; Saito K; Kato K; Fischer R; Berquand A; Kessler BM; Lappin T; Frizzell N; Soga T; Adam J; Pollard PJ
    Cell Rep; 2013 Mar; 3(3):689-700. PubMed ID: 23499446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fumarate Mediates a Chronic Proliferative Signal in Fumarate Hydratase-Inactivated Cancer Cells by Increasing Transcription and Translation of Ferritin Genes.
    Kerins MJ; Vashisht AA; Liang BX; Duckworth SJ; Praslicka BJ; Wohlschlegel JA; Ooi A
    Mol Cell Biol; 2017 Jun; 37(11):. PubMed ID: 28289076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability.
    Isaacs JS; Jung YJ; Mole DR; Lee S; Torres-Cabala C; Chung YL; Merino M; Trepel J; Zbar B; Toro J; Ratcliffe PJ; Linehan WM; Neckers L
    Cancer Cell; 2005 Aug; 8(2):143-53. PubMed ID: 16098467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cascade Fumarate Hydratase mutation screening allows early detection of kidney tumour: a case report.
    Chan MMY; Barnicoat A; Mumtaz F; Aitchison M; Side L; Brittain H; Bates AWH; Gale DP
    BMC Med Genet; 2017 Jul; 18(1):79. PubMed ID: 28747166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status.
    Bardella C; El-Bahrawy M; Frizzell N; Adam J; Ternette N; Hatipoglu E; Howarth K; O'Flaherty L; Roberts I; Turner G; Taylor J; Giaslakiotis K; Macaulay VM; Harris AL; Chandra A; Lehtonen HJ; Launonen V; Aaltonen LA; Pugh CW; Mihai R; Trudgian D; Kessler B; Baynes JW; Ratcliffe PJ; Tomlinson IP; Pollard PJ
    J Pathol; 2011 Sep; 225(1):4-11. PubMed ID: 21630274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors.
    Hoekstra AS; de Graaff MA; Briaire-de Bruijn IH; Ras C; Seifar RM; van Minderhout I; Cornelisse CJ; Hogendoorn PC; Breuning MH; Suijker J; Korpershoek E; Kunst HP; Frizzell N; Devilee P; Bayley JP; Bovée JV
    Oncotarget; 2015 Nov; 6(36):38777-88. PubMed ID: 26472283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fumarate hydratase inactivation in renal tumors: HIF1α, NRF2, and "cryptic targets" of transcription factors.
    Ooi A; Furge KA
    Chin J Cancer; 2012 Sep; 31(9):413-20. PubMed ID: 22776233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced expression of fumarate hydratase in clear cell renal cancer mediates HIF-2α accumulation and promotes migration and invasion.
    Sudarshan S; Shanmugasundaram K; Naylor SL; Lin S; Livi CB; O'Neill CF; Parekh DJ; Yeh IT; Sun LZ; Block K
    PLoS One; 2011; 6(6):e21037. PubMed ID: 21695080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiling in progressive stages of fumarate-hydratase deficiency: the contribution of metabolic changes to tumorigenesis.
    Ashrafian H; O'Flaherty L; Adam J; Steeples V; Chung YL; East P; Vanharanta S; Lehtonen H; Nye E; Hatipoglu E; Miranda M; Howarth K; Shukla D; Troy H; Griffiths J; Spencer-Dene B; Yusuf M; Volpi E; Maxwell PH; Stamp G; Poulsom R; Pugh CW; Costa B; Bardella C; Di Renzo MF; Kotlikoff MI; Launonen V; Aaltonen L; El-Bahrawy M; Tomlinson I; Pollard PJ
    Cancer Res; 2010 Nov; 70(22):9153-65. PubMed ID: 20978192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling.
    Sullivan LB; Martinez-Garcia E; Nguyen H; Mullen AR; Dufour E; Sudarshan S; Licht JD; Deberardinis RJ; Chandel NS
    Mol Cell; 2013 Jul; 51(2):236-48. PubMed ID: 23747014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for cytosolic fumarate hydratase in urea cycle metabolism and renal neoplasia.
    Adam J; Yang M; Bauerschmidt C; Kitagawa M; O'Flaherty L; Maheswaran P; Özkan G; Sahgal N; Baban D; Kato K; Saito K; Iino K; Igarashi K; Stratford M; Pugh C; Tennant DA; Ludwig C; Davies B; Ratcliffe PJ; El-Bahrawy M; Ashrafian H; Soga T; Pollard PJ
    Cell Rep; 2013 May; 3(5):1440-8. PubMed ID: 23643539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.